Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H rorsman

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Acta Dermato-Venereologica|January 1, 1976
Demonstration of 3-methoxytyrosine in the urine of melanoma patientsG Agrup, M Bengtsson, B Falck, et al.
Molecular Medicine (Cambridge, Mass.)|January 1, 1996
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reactionE Rosengren, R Bucala, P Aman, et al.
FEBS Letters|December 12, 1997
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomeraseE Rosengren, P Aman, S Thelin, et al.
Acta Dermato-Venereologica|January 1, 1975
Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasisG Agrup, P Agrup, T Andersson, et al.
Acta Dermato-Venereologica|January 1, 1977
5-S-cysteinyldopa in the urine of melanoma patientsG Agrup, P Agrup, T Andersson, et al.
Acta Dermato-Venereologica|January 1, 1979
5 years' experience of 5-S-cysteinyldopa in melanoma diagnosisG Agrup, P Agrup, T Andersson, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Acta Dermato-Venereologica|January 1, 1976
Demonstration of 3-methoxytyrosine in the urine of melanoma patientsG Agrup, M Bengtsson, B Falck, et al.
Molecular Medicine (Cambridge, Mass.)|January 1, 1996
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reactionE Rosengren, R Bucala, P Aman, et al.
FEBS Letters|December 12, 1997
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomeraseE Rosengren, P Aman, S Thelin, et al.
Acta Dermato-Venereologica|January 1, 1975
Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasisG Agrup, P Agrup, T Andersson, et al.
Acta Dermato-Venereologica|January 1, 1977
5-S-cysteinyldopa in the urine of melanoma patientsG Agrup, P Agrup, T Andersson, et al.
Acta Dermato-Venereologica|January 1, 1979
5 years' experience of 5-S-cysteinyldopa in melanoma diagnosisG Agrup, P Agrup, T Andersson, et al.
Pageof 13